XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Cumulative change in accounting principle upon adoption of new accounting pronouncement
Cumulative change in accounting principle upon adoption of new accounting pronouncement
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2019   51,514            
Beginning balance at Dec. 31, 2019 $ 985,639 $ 5,151 $ 786,242 $ 195,813 $ (6,032) $ 4,465 $ (16,876) $ (16,876)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Comprehensive income 63,175     48,417   14,758    
Stock based compensation (in shares)   39            
Stock based compensation expense 5,471   5,471          
Common stock transactions related to stock based employee benefit plans (in shares)   395            
Common stock transactions related to stock based employee benefit plans (1,918) $ 44 (53)   (1,909)      
Common stock issued for stock options (in shares)   58            
Common stock issued for stock options 698 $ 6 692          
Issuance of common stock, pursuant to acquisition (in shares)   3,163            
Issuance of common stock, pursuant to acquisition 62,152 $ 316 61,836          
Increase (decrease) in shares during period (in shares)   3,655            
Increase (decrease) in stockholders' equity during period 112,702 $ 366 67,946 31,541 (1,909) 14,758    
Ending balance (in shares) at Sep. 30, 2020   55,169            
Ending balance at Sep. 30, 2020 1,098,341 $ 5,517 854,188 227,354 (7,941) 19,223    
Beginning balance (in shares) at Jun. 30, 2020   52,991            
Beginning balance at Jun. 30, 2020 1,030,603 $ 5,299 811,321 204,726 (8,037) 17,294    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Comprehensive income 24,557     22,628   1,929    
Stock based compensation (in shares)   39            
Stock based compensation expense 1,948   1,948          
Common stock transactions related to stock based employee benefit plans (in shares)   18            
Common stock transactions related to stock based employee benefit plans 96 $ 6 (6)   96      
Common stock issued for stock options (in shares)   1            
Common stock issued for stock options 16   16          
Issuance of common stock, pursuant to acquisition (in shares)   2,120            
Issuance of common stock, pursuant to acquisition 41,121 $ 212 40,909          
Increase (decrease) in shares during period (in shares)   2,178            
Increase (decrease) in stockholders' equity during period 67,738 $ 218 42,867 22,628 96 1,929    
Ending balance (in shares) at Sep. 30, 2020   55,169            
Ending balance at Sep. 30, 2020 1,098,341 $ 5,517 854,188 227,354 (7,941) 19,223    
Beginning balance (in shares) at Dec. 31, 2020   55,243            
Beginning balance at Dec. 31, 2020 1,130,402 $ 5,524 856,092 256,701 (8,285) 20,370    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Comprehensive income 72,972     88,073   (15,101)    
Stock based compensation (in shares)   23            
Stock based compensation expense 6,620   6,620          
Common stock transactions related to stock based employee benefit plans (in shares)   139            
Common stock transactions related to stock based employee benefit plans (1,884) $ 17 (40)   (1,861)      
Common stock issued for stock options (in shares)   257            
Common stock issued for stock options 5,172 $ 25 5,147          
Issuance of common stock, pursuant to acquisition (in shares)   2,687            
Issuance of common stock, pursuant to acquisition 86,487 $ 269 86,218          
Conversion of options, pursuant to acquisition 5,607   5,607          
Dividends on common stock (14,856)     (14,856)        
Increase (decrease) in shares during period (in shares)   3,106            
Increase (decrease) in stockholders' equity during period 160,118 $ 311 103,552 73,217 (1,861) (15,101)    
Ending balance (in shares) at Sep. 30, 2021   58,349            
Ending balance at Sep. 30, 2021 1,290,520 $ 5,835 959,644 329,918 (10,146) 5,269    
Beginning balance (in shares) at Jun. 30, 2021   55,436            
Beginning balance at Jun. 30, 2021 1,182,347 $ 5,544 862,598 314,584 (10,180) 9,801    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Comprehensive income 18,412     22,944   (4,532)    
Stock based compensation (in shares)   23            
Stock based compensation expense 2,358   2,358          
Common stock transactions related to stock based employee benefit plans (in shares)   25            
Common stock transactions related to stock based employee benefit plans 17 $ 5 (22)   34      
Common stock issued for stock options (in shares)   178            
Common stock issued for stock options 2,902 $ 17 2,885          
Issuance of common stock, pursuant to acquisition (in shares)   2,687            
Issuance of common stock, pursuant to acquisition 86,487 $ 269 86,218          
Conversion of options, pursuant to acquisition 5,607   5,607          
Dividends on common stock (7,610)     (7,610)        
Increase (decrease) in shares during period (in shares)   2,913            
Increase (decrease) in stockholders' equity during period 108,173 $ 291 97,046 15,334 34 (4,532)    
Ending balance (in shares) at Sep. 30, 2021   58,349            
Ending balance at Sep. 30, 2021 $ 1,290,520 $ 5,835 $ 959,644 $ 329,918 $ (10,146) $ 5,269